Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 110143
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110143
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110143
Table 1 Comparison of baseline characteristics, mean ± SD/%
| Characteristic | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Age (years) | 42.3 ± 8.4 | 42.7 ± 8.8 | 0.21 | > 0.05 |
| Gender (male/female) | 47/13 | 46/14 | 0.12 | > 0.05 |
| Disease duration (months) | 18.5 ± 5.6 | 18.2 ± 5.4 | 0.32 | > 0.05 |
| Fistula type (single/multiple) | 20/40 | 22/38 | 0.24 | > 0.05 |
| Comorbidities (yes/no) | 15/45 | 14/46 | 0.15 | > 0.05 |
| Average | 7.2 ± 1.5 | 6.8 ± 1.4 | 0.36 | > 0.05 |
| Preoperative anal function score (Wexner score) | 2.1 ± 0.6 | 2.0 ± 0.5 | 0.22 | > 0.05 |
| Postoperative complications rate | 20 | 10 | 1.53 | < 0.05 |
| Postoperative hospital stays (days) | 7.5 ± 2.0 | 6.0 ± 1.5 | 1.84 | < 0.05 |
| Postoperative anal function score (Wexner score) | 3.5 ± 1.0 | 2.5 ± 0.8 | 1.71 | < 0.05 |
| Treatment satisfaction | 75 | 85 | 1.62 | < 0.05 |
| Recurrence rate during follow-up | 15 | 5 | 1.95 | < 0.05 |
Table 2 Time-comprehensive comparison of postoperative outcomes, mean ± SD
| Characteristic | Conventional treatment group | Optimized treatment group | Statistical value | P value |
| Postoperative pain score (0-10 scale) | 6.5 ± 1.2 | 4.2 ± 1.0 | 1.95 | < 0.001 |
| Postoperative infection rate (%) | 20 | 10 | 1.51 | < 0.05 |
| Postoperative quality of life score (quality of life, 0-100 scale) | 65 ± 10 | 75 ± 9 | 2.02 | < 0.001 |
| Postoperative follow-up duration (months) | 6 ± 1 | 6 ± 1 | 0.11 | > 0.05 |
| Postoperative sexual function score (0-10 scale) | 7.0 ± 1.5 | 8.0 ± 1.2 | 1.61 | < 0.05 |
| Postoperative bowel function score (0-10 scale) | 6.0 ± 1.0 | 7.5 ± 0.8 | 1.92 | < 0.05 |
Table 3 Healing time and recovery indicator analysis, mean ± SD
| Characteristic | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Complete healing time (days) | 28.3 ± 5.8 | 21.5 ± 4.2 | 2.35 | < 0.001 |
| Anal function recovery time (days) | 19.7 ± 4.5 | 14.2 ± 3.1 | 2.48 | < 0.001 |
| Wound epithelialization time (days) | 25.1 ± 4.9 | 18.8 ± 3.6 | 2.61 | < 0.001 |
| Time to first ambulation (hours) | 18.4 ± 3.2 | 12.6 ± 2.8 | 2.14 | < 0.001 |
| Time to normal diet resumption (days) | 4.8 ± 1.6 | 2.9 ± 1.1 | 2.31 | < 0.001 |
| Time to first painless defecation (days) | 8.7 ± 2.4 | 5.3 ± 1.9 | 2.67 | < 0.001 |
| Time to complete discharge cessation (days) | 15.2 ± 4.1 | 10.8 ± 3.2 | 2.05 | < 0.001 |
| Time to return to work (days) | 21.6 ± 6.3 | 16.4 ± 4.7 | 1.98 | < 0.01 |
Table 4 Comparison of surgical-related indicators, mean ± SD/%
| Indicator | Conventional group (n = 62) | Optimized group (n = 70) | Statistic | P value |
| Operation time (minutes) | 38.7 ± 6.9 | 45.2 ± 8.3 | t = 1.89 | 0.034 |
| Intraoperative blood loss (mL) | 18.7 ± 5.8 | 15.3 ± 4.2 | t = 1.76 | 0.041 |
| Complete fistula closure rate | 0.871 (54/62) | 0.957 (67/70) | χ² = 2.12 | 0.035 |
| Anesthesia duration (minutes) | 52.3 ± 8.1 | 58.6 ± 9.4 | t = 1.74 | 0.044 |
| Intraoperative fistula tract identification rate | 0.919 (57/62) | 0.986 (69/70) | χ² = 2.31 | 0.021 |
| Seton placement success rate | 0.887 (55/62) | 0.971 (68/70) | χ² = 2.45 | 0.008 |
Table 5 Medication use and treatment compliance analysis, mean ± SD
| Characteristic | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Postoperative analgesic use (days) | 6.2 ± 2.1 | 3.8 ± 1.2 | t = 2.74 | < 0.001 |
| Antibiotic use duration (days) | 7.3 ± 2.4 | 4.1 ± 1.5 | t = 2.89 | < 0.001 |
| Treatment compliance rate | 0.903 (56/62) | 0.971 (68/70) | χ² = 1.98 | 0.048 |
| Total medication cost (dollars) | 286.4 ± 54.7 | 198.3 ± 41.2 | t = 2.56 | < 0.001 |
| Medication-related adverse events | 0.161 (10/62) | 0.071 (5/70) | χ² = 2.23 | 0.026 |
| Patient-reported medication satisfaction (0-10) | 6.8 ± 1.4 | 8.2 ± 1.1 | t = 2.41 | < 0.001 |
| Medication dose adjustment times | 2.7 ± 1.3 | 1.4 ± 0.8 | t = 2.18 | 0.003 |
Table 6 Comparison of postoperative complications, n (%)
| Complication type | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Wound infection | 8 (13.3) | 4 (6.7) | 0.67 | 0.21 |
| Mild anal incontinence | 7 (11.7) | 0 (0.0) | 1.17 | < 0.05 |
| Others | 3 (5.0) | 1 (1.7) | 0.50 | 0.32 |
| Postoperative bleeding | 5 (8.3) | 2 (3.3) | 0.83 | 0.24 |
| Urinary retention | 6 (10.0) | 3 (5.0) | 1.00 | 0.35 |
| Prolonged pain duration | 10 (16.7) | 4 (6.7) | 1.67 | < 0.05 |
| Recurrence | 9 (15.0) | 3 (5.0) | 1.50 | < 0.05 |
| Extended hospital stays | 7 (11.7) | 2 (3.3) | 1.17 | < 0.05 |
| Medication dependence | 12 (20.0) | 5 (8.3) | 1.20 | < 0.05 |
| Infection (other than wound) | 4 (6.7) | 1 (1.7) | 0.67 | 0.18 |
| Psychological issues | 5 (8.3) | 2 (3.3) | 0.83 | 0.24 |
Table 7 Comprehensive comparison of postoperative outcomes and quality of life, n (%)
| Characteristic | Conventional treatment group (n = 62) | Optimized treatment group (n = 70) | Statistical value | P value |
| Patient satisfaction | χ² = 12.35 | < 0.001 | ||
| Very satisfied | 40 (64.5) | 59 (84.3) | ||
| Satisfied | 18 (29.0) | 11 (15.7) | ||
| Dissatisfied | 4 (6.5) | 0 (0) | ||
| Complete work/Life recovery | 0.839 (52/62) | 0.957 (67/70) | χ² = 2.15 | 0.032 |
| Long-term quality of life score (0-100) | 72.3 ± 8.4 | 83.6 ± 6.2 | t = 2.67 | < 0.001 |
| Patient treatment recommendation rate | 0.710 (44/62) | 0.929 (65/70) | χ² = 2.84 | < 0.001 |
| Repeat surgery requirement | 0.081 (5/62) | 0.014 (1/70) | χ² = 2.32 | 0.020 |
| Return to normal social activities | 0.790 (49/62) | 0.943 (66/70) | χ² = 2.41 | 0.008 |
- Citation: Liu JF, Wang Y, Peng XS, Li QL. Enhanced surgical management of complex anal fistulas via integrated traditional Chinese medicine: A retrospective cohort study. World J Gastrointest Surg 2025; 17(11): 110143
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/110143.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.110143
